Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors
Andersson, H.O., Fridborg, K., Lowgren, S., Alterman, M., Muhlman, A., Bjorsne, M., Garg, N., Kvarnstrom, I., Schaal, W., Classon, B., Karlen, A., Danielsson, U.H., Ahlsen, G., Nillroth, U., Vrang, L., Oberg, B., Samuelsson, B., Hallberg, A., Unge, T.(2003) Eur J Biochem 270: 1746-1758
- PubMed: 12694187 
- DOI: 10.1046/j.1432-1033.2003.03533.x
- Primary Citation of Related Structures:  
1D4H, 1D4I, 1D4J, 1EBW, 1EBY, 1EBZ, 1EC1, 1EC2, 1EC3 - PubMed Abstract: 
HIV-1 protease is an important target for treatment of AIDS, and efficient drugs have been developed. However, the resistance and negative side effects of the current drugs has necessitated the development of new compounds with different binding patterns ...